TITLE

Gambiense sleeping sickness: re-emerging and soon untreatable?

AUTHOR(S)
Van Nieuwenhove, Simon
PUB. DATE
November 2000
SOURCE
Bulletin of the World Health Organization;2000, Vol. 78 Issue 11, p1283
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Comments on the return of sleeping sickness caused by Trypanosoma brucei gambiense. Deterioration and disruption of control activities; Problems on the implementation of active case detection and successful treatment; Gap between scientific progress and the implementation of eflornithine in the field; Use of nifurtimox for compassionate treatment.
ACCESSION #
4002465

 

Related Articles

  • Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial. Pepin, Jacques; Khonde, Nzambi // Bulletin of the World Health Organization;2000, Vol. 78 Issue 11, p1284 

    Compares the effectiveness of 7 days of intravenous eflornithine with the standard 14-day regimen in the treatment of late-stage Trypanosoma brucei gambiense trypanosomiasis. Use of a randomized controlled trial; Death of some patients during treatment; Difference in response to treatment...

  • Sleeping bug: scientists identify drug resistance mechanism.  // Africa Health;Mar2012, Vol. 34 Issue 3, p12 

    The article focuses on the study conducted by the researchers in Greta Britain, which reveals several ways by which parasite Trypanosoma brucei can resist drugs used in treating sleeping sickness.

  • New Clues to Sleeping Sickness.  // JAMA: Journal of the American Medical Association;1/2/2013, Vol. 309 Issue 1, p20 

    The article informs that a new research conducted by the scientists of Germany, Sweden and the U.S. has explained the structure of a key enzyme named "Trypanosoma brucei cysteine protease cathepsin B," (TbCatB) from the parasite that causes African trypanosomiasis or sleeping sickness.

  • Estimates of the duration of the early and late stage of gambiense sleeping sickness. Checchi, Francesco; Filipe, João A. N.; Haydon, Daniel T.; Chandramohan, Daniel; Chappuis, François // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: The durations of untreated stage 1 (early stage, haemo-lymphatic) and stage 2 (late stage, meningo-encephalitic) human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense are poorly quantified, but key to predicting the impact of screening on transmission....

  • Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. Fèvre, Eric M.; Odiit, Martin; Coleman, Paul G.; Woolhouse, Mark E. J.; Welburn, Susan C. // BMC Public Health;2008, Vol. 8 Issue 1, p96 

    Background: Zoonotic sleeping sickness, or HAT (Human African Trypanosomiasis), caused by infection with Trypanosoma brucei rhodesiense, is an under-reported and neglected tropical disease. Previous assessments of the disease burden expressed as Disability-Adjusted Life Years (DALYs) for this...

  • African Trypanosomes: Will the Twain Meet? Deresinski, Stan // Clinical Infectious Diseases;3/15/2006, Vol. 42 Issue 6, preceding p739 

    The article reports about African Trypanosomes, a sleeping sickness dieses. The human African trypanosomiasis disease exists in two forms: One is caused by Trypanosoma brucei subspecies ganbienese. Western and Central Africa is mostly affected by this dieses. Second is caused by T. brucei...

  • Trypanosomes, Infection and Immunity. Kaminsky, Ronald; Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p666 

    The article provides an encyclopedia entry on trypanosomes. Trypanosomes are protozoan parasites. Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense are species of trypanosomes that are pathogenic to man. These species can also cause sleeping sickness. Moreover, the article also...

  • Diagnostic Accuracy of Loopamp Trypanosoma brucei Detection Kit for Diagnosis of Human African Trypanosomiasis in Clinical Samples. Mitashi, Patrick; Hasker, Epco; Ngoyi, Dieudonné Mumba; Pyana, Pati Patient; Lejon, Veerle; Van der Veken, Wim; Lutumba, Pascal; Büscher, Philippe; Boelaert, Marleen; Deborggraeve, Stijn // PLoS Neglected Tropical Diseases;Oct2013, Vol. 7 Issue 10, p1 

    Background: Molecular methods have great potential for sensitive parasite detection in the diagnosis of human African trypanosomiasis (HAT), but the requirements in terms of laboratory infrastructure limit their use to reference centres. A recently developed assay detects the Trypanozoon...

  • Parasitology: Peculiar lipid production. Finkelstein, Joshua M. // Nature;8/31/2006, Vol. 442 Issue 7106, p995 

    The article features the parasite Trypanosoma brucei, responsible for the African trypanosomiasis or sleeping sickness. According to the World health Organization, about 50,000 people die due this disease every year. The parasite survives in the blood stream by creating a lipid coating on its...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics